Dachaigh › Sarcoma Synovial
Sgrùdaidhean clionaigeach Sarcoma Synovial a’ fastadh anns na SA
Tha 13 sgrùdaidhean airson Sarcoma Synovial a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Boston, MA5 sgrùdaidhean
- Chicago, IL4 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- St. Louis, MO3 sgrùdaidhean
Le stàit
- California5 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- Missouri3 sgrùdaidhean
- New York3 sgrùdaidhean
- Pennsylvania3 sgrùdaidhean
- Texas4 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06644755Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT05711615N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
A’ fastadhÌre 1 tràth
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07261657SPEARHEAD-3 Pediatric Study
A’ fastadhÌre 1/2
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05642455NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06239272Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
A’ fastadhÌre 1
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06083883AOH1996 for the Treatment of Refractory Solid Tumors
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT05227326Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
A’ fastadhÌre 1/2
6 Months – 25 Years · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06625190XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Ògmh 2026 · NCT06571734Synovial Sarcoma Registry / Biospecimen Repository
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 9 Ògmh 2026 · NCT05910307Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Gearr 2026 · NCT03016819HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
A’ fastadhÌre 1
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 22 Faoi 2026 · NCT04995003ACTengine® IMA203 Combined With mRNA-4203
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Faoi 2026 · NCT06946225Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.